Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when IIPR files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsIIPR reports Q2 2026: $63.3M revenue, $1.83 AFFO/share; issues $402.5M exchangeable notes
Filed August 3, 2026 · Period ending August 3, 2026 · ~1 min read
Key Changes
-
high
Q2 2026 revenue $63.3M, net income $40.7M ($1.36/share), AFFO $53.0M ($1.83/share); revenue up 0.7% YoY driven by new leases and rent escalations, offset by property sales and tenant defaults.
Exhibit 99.1 view on EDGAR → -
high
Issued $402.5M of 6.0% exchangeable senior notes due 2029; used $80.5M of proceeds to repurchase 1.47M shares at $60.58/share, remainder for working capital and debt repayment; fully repaid $291M notes due 2026.
Exhibit 99.1 view on EDGAR → -
high
Completed $270M IQHQ investment ($100M revolver at 13.5% yield, $170M preferred at 15.0% yield); funded $120M preferred equity in Q2, generating $8.5M interest/dividend income in the quarter.
Exhibit 99.1 view on EDGAR → -
medium
Sold two properties for $91.8M gross proceeds: Texas land parcel for $3.3M (recorded $4.9M loss), New York property for $88.5M with $49M seller financing (recorded $16.7M gain).
Exhibit 99.1 view on EDGAR → -
medium
Reached tentative arrangements with new tenants for four 4Front assets (488K sq ft across IL, WA, MA); arrangements subject to licensing approvals, expected effective by year-end 2026 or early 2027 following receivership conclusion.
Exhibit 99.1 view on EDGAR →
Summary
Innovative Industrial Properties reported second-quarter 2026 results showing stable operating performance and active capital management. Revenue of $63.3 million and AFFO of $1.83 per share reflect modest year-over-year growth, with new leases and contractual rent escalations substantially offset by property sales and tenant defaults.
The company completed a $402.5 million exchangeable notes offering at 6.0%, using $80.5 million to repurchase shares at $60.58 and the remainder to retire its $291 million notes due 2026 and fund general corporate purposes. The company fully funded its $270 million IQHQ investment during the quarter, deploying $120 million in preferred equity to complete the commitment announced in August 2025.
The investment comprises a $100 million revolver at 13.5% yield and $170 million in preferred stock at 15.0% yield, generating $8.5 million in income during Q2. IIPR also sold two properties for $91.8 million in gross proceeds and reached tentative arrangements with new tenants for four assets previously leased to 4Front, subject to licensing approvals and receivership proceedings expected to conclude by year-end 2026 or early 2027. The balance sheet remains lightly leveraged at 1.7x net leverage and 14% net debt to total gross assets, with $300 million in available liquidity.
Section-by-Section Diff
Event · Item 7.01 — Regulation FD Disclosure
IIPR posted an investor presentation on its website under Regulation FD.
Show 1 minor / wording change
Added in current filing · verify on EDGAR →
On August 3, 2026, the Company posted on an investor presentation on it its website located at www.innovativeindustrialproperties.com. A copy of the investor presentation is attached hereto as Exhibit 99.3 and is incorporated by reference herein.
The company posted an investor presentation on its website and filed it as Exhibit 99.3. This is a routine Regulation FD disclosure to ensure equal access to information. The filing does not disclose the content of the presentation.
Event · Exhibit 99.1
IIPR reported Q2 2026 results: $63.3M revenue, $1.36 EPS, $1.83 AFFO/share; issued $402.5M exchangeable notes, repurchased $89M stock, repaid $291M notes.
Added in current filing · view on EDGAR →
Completed an upsized private offering of $402.5 million aggregate principal amount of 6.0% exchangeable senior notes due 2029 (the "Exchangeable Notes"). ... •During the quarter, the Company repurchased 1,468,542 shares of its common stock for $89.0 million at a weighted average price of approximately $60.58 per share, $80.5 million of which were purchased concurrently with the offering of Exchangeable Notes.
IIPR completed a private offering of $402.5 million of 6.0% exchangeable senior notes due 2029. The company used $80.5 million of the net proceeds to repurchase 1,468,542 shares of common stock at a weighted average price of $60.58 per share, with the remainder intended for working capital, general corporate purposes, debt repayment, and future investments. The company also fully repaid its $291 million of 5.50% Unsecured Senior Notes due 2026 during the quarter.
Added in current filing · view on EDGAR →
The Company has reached tentative arrangements with prospective new tenants for the four assets leased to 4Front, including a 250,000 square foot asset in Illinois, a 114,000 square foot asset in Washington, and two assets in Massachusetts totaling 124,000 square feet. Each of these arrangements is subject to certain contingencies to effectiveness (such as licensing transfer approvals) and are expected to go into effect at the conclusion of receivership proceedings, anticipated to occur by year end 2026 or early 2027.
IIPR has reached tentative arrangements with prospective new tenants for four assets previously leased to 4Front, totaling 488,000 square feet across Illinois, Washington, and Massachusetts. These arrangements are subject to contingencies including licensing transfer approvals and are expected to become effective following the conclusion of receivership proceedings, anticipated by year-end 2026 or early 2027. The company also resolved litigation with PharmaCann and immediately leased the Ohio property to Curaleaf after PharmaCann surrendered it in April 2026.
Event · Exhibit 99.2
IIPR reported Q2 2026 results: $63.3M revenue, $40.7M net income, $1.70 normalized FFO/share; sold two properties for $91.8M; issued $402.5M exchangeable notes.
Added in current filing · view on EDGAR →
Total Revenues $63,315 ... Net income attributable to common stockholders $40,665 ... Normalized FFO attributable to common stockholders – diluted (“Normalized FFO”) (1) $49,214 ... Normalized FFO per common share – diluted(1) $1.70
IIPR reported Q2 2026 total revenues of $63.3 million, net income attributable to common stockholders of $40.7 million ($1.36 per diluted share), and normalized FFO of $49.2 million ($1.70 per diluted share). The normalized FFO per share of $1.70 was flat quarter-over-quarter but up from $1.60 in Q2 2025.
Added in current filing · view on EDGAR →
Rentable Sale Total State Closing / Execution Square Feet Price(1) Sale / PSF Dispositions Texas May-26 63 $3,267 $52 New York May-26 389 88,500 228 Total / Wtd. Avg. 452 $91,767 $203
IIPR sold two properties in Q2 2026: a 63,000 square foot facility in Texas for $3.3 million and a 389,000 square foot facility in New York for $88.5 million, totaling $91.8 million in gross proceeds. The company recognized an $11.8 million gain on these sales.
Added in current filing · view on EDGAR → · paraphrased
Principal payments on debt and term loans (311,274) ... Notes due 2026, net $— $290,602
IIPR repaid $311.3 million in debt during the six months ended June 30, 2026, including the full retirement of its Notes due 2026 (which had a $290.6 million balance at year-end 2025). The company also drew $148.7 million in new term loans during the period.
Added in current filing · view on EDGAR →
Life science investments 275,888 152,665 ... Investments in life science financial instruments (120,000)
IIPR increased its life science investments from $152.7 million at December 31, 2025 to $275.9 million at June 30, 2026, deploying $120.0 million in new capital during the six-month period. These investments include secured notes, a revolving credit facility, and preferred equity in IQHQ and other life science-related borrowers.
Event · Exhibit 99.3
IIPR filed an investor presentation deck summarizing its Q2 2026 portfolio, life science investments, and financial position.
Added in current filing · view on EDGAR →
$2.4B Total Invested Capital(1) 108 Total Properties 11.9 Years Weighted Average Lease Length(2) $63.3M Q2 2026 Total Revenue $270M Financial Investment in Life Science 19 U.S. States $1.2B+ Dividends Paid Since Inception in ‘16
The company disclosed its Q2 2026 portfolio metrics: $2.4 billion in total invested capital across 108 properties in 19 states, with a weighted average lease length of 11.9 years. Q2 2026 total revenue was $63.3 million. The company has paid over $1.2 billion in dividends since its 2016 inception and holds a $270 million financial investment in the life science sector.
Added in current filing · view on EDGAR →
(5) These leases are in default, as disclosed in our 8-K filed on March 14, 2025. (6) These leases are in default, as disclosed in our 8-K filed on March 28, 2025. (7) These leases are in default, as disclosed in our 8-K filed on July 21, 2026.
The presentation references three sets of leases in default, disclosed in prior 8-Ks filed on March 14, 2025, March 28, 2025, and July 21, 2026. The presentation does not quantify the impact of these defaults, but they represent credit risk in the portfolio.
Added in current filing · view on EDGAR →
AFFO attributable to common stockholders $53,009 ... AFFO per common share – diluted $1.83
The company reported Q2 2026 adjusted funds from operations (AFFO) of $53.0 million, or $1.83 per diluted share. Annualized, this represents $7.32 per share, reflecting a 7% compound annual growth rate from 2020 to Q2 2026 annualized.
Added in current filing · view on EDGAR → · paraphrased
14% Net Debt to Total Gross Assets(1) 1.7x LQA Net Leverage Ratio (2) $300M Liquidity Available (3) ... Gross Debt, $623.6M Preferred Equity, $141.7M Common Equity Market Capitalization, $1.7B
The company disclosed a net leverage ratio of 1.7x (last-quarter-annualized adjusted EBITDA) and net debt to total gross assets of 14% as of June 30, 2026. Gross debt totaled $623.6 million, with $300 million in available liquidity. The balance sheet remains lightly leveraged relative to the REIT sector.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Aug 4, 2026 · How we verify